Selected Grants
Metabolic Actions of Glucagon
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2025 - 2030Endocrinology and Metabolism Training Program
Inst. Training Prgm or CMEPrincipal Investigator · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2024 - 2029Alpha- to Beta-Cell Communication in Health and Disease
ResearchCo-Principal Investigator · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2024 - 2029Gut epithelial control of nutrient reward
ResearchCo-Mentor · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2024 - 2028Targeting alpha-cell GPCRs to stimulate glucagon and counter hypoglycemia
ResearchCo-Mentor · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2022 - 2027Changing the T1DE: A randomized controlled trial comparing ACT to supportive diabetes counseling
ResearchCo Investigator · Awarded by Juvenile Diabetes Research Foundation · 2022 - 2027Duke Program of Training in Pulmonary ReSearch to Promote, Engage and Retain Academic Researchers (PROSPER)
Inst. Training Prgm or CMEPreceptor · Awarded by National Heart, Lung, and Blood Institute · 2022 - 2026Novel assays for proglucagon peptides to understand alpha cell function in health and diabetes
ResearchCo Investigator · Awarded by Leona M. and Harry B. Helmsley Charitable Trust · 2024 - 2026Rapid sugar sensing from gut to brain
FellowshipCo-Mentor · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2023 - 2026Gut glutamatergic neurotransmission in sugar preference
ResearchCollaborator · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2021 - 2026Injectable PEG-like Conjugate for Sustained Delivery of a Peptide Drug for Type 2 Diabetes Treatment
ResearchCo Investigator · Awarded by National Institutes of Health · 2020 - 2025Novel metabolic actions of GIP
ResearchCo-Principal Investigator · Awarded by National Institute of Diabetes and Digestive and Kidney Diseases · 2020 - 2025North Carolina Diabetes Research Center (NCDRC)
ResearchPrincipal Investigator · Awarded by Wake Forest University Health Sciences · 2020 - 2025Mechanisms of insulin secretion mediated by alpha cells
ResearchInvestigator · Awarded by National Institutes of Health · 2019 - 2024Glucagon and insulin act cooperatively in the regulation of prandial hepatic glycogen metabolism
ResearchCo-Mentor · Awarded by National Institutes of Health · 2021 - 2023Mechanisms that Direct Airway Remodeling in Obese Asthma
ResearchCo Investigator · Awarded by National Institutes of Health · 2017 - 2023Duke Training Grant in Nephrology
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 1995 - 2023Serotonin as a Novel Biomarker for Progression to Type 2 Diabetes in Obese Adolescents
ResearchAdvisor · Awarded by National Institutes of Health · 2018 - 2023IPA - Radha Krishna
ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2019 - 2021IPA - Cris Slentz
ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2019 - 2021IPA - Lucy Piner
ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2019 - 2021IPA-Leslie Kelly
ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2019 - 2021Role of Islet GLP-1 and DPP-4 in Insulin Secretion
Clinical TrialPrincipal Investigator · Awarded by Merck Sharp & Dohme · 2015 - 2021The Role of Islet DPP4 for Regulation of Glucose Homeostasis
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2021INCRETIN ACTION IN PHYSIOLOGY AND DIABETES
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2014 - 2021IPA - Lorraine Elliott-Penry
Clinical TrialPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2019 - 2021Nutrient-dependent action of glucagon and GLP-1 in glucose metabolism and insulin secretion
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2019 - 2020A multi-center, randomized, double-blind, parallel-group, multiple dose, adaptive study assessing the pharmacokinetics, pharmacodynamics, safety and tolerability of TTP399 in adult patients with type 1 diabetes mellitus.
Clinical TrialPrincipal Investigator · Awarded by vTv Therapeutics LLC · 2018 - 2020Assessing the Role of Glucose-Dependent Insulinotropic Polypeptide to Mediate Improved Beta-Cell Function Following Bariatric Surgery
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2019IPA- Leslie Kelly
ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2017 - 2019IPA - Andrew Hoselton
ResearchPrincipal Investigator · Awarded by Durham Veterans Affairs Medical Center · 2017 - 2019Thermo Lumos Tribrid High-Resolution Accurate-Mass Tandem Mass Spectrometer
EquipmentMajor User · Awarded by National Institutes of Health · 2018 - 2019The Role of Ghrelin to Regulate Insulin Secretion in Health and Diabetes
ResearchInvestigator · Awarded by National Institutes of Health · 2013 - 2019The Role of Vitamin D in Established Type 2 Diabetes
ResearchPrincipal Investigator · Awarded by Tufts Medical Center · 2015 - 2018A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety and Efficacy of LGD-6972 in Patients with Type 2 Diabetes Mellitus
Clinical TrialPrincipal Investigator · Awarded by Ligand Pharmaceuticals, Inc. · 2016 - 2017The Role of Glucagon in Diabetic Ketoacidosis
ResearchPrincipal Investigator · Awarded by Endocrine Fellows Foundation · 2016 - 2017External Relationships
- Advent Health- Translational Research Institute
- American Diabetes Association
- Eli Lilly & Co.
- MBX Bioscience
- Structure Therapeutics
- Sun Pharmaceuticals
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.